Good Perspective! Maybe there is still hope.
Re-read the 6th September Covid- 19 Trial Update (ADDENDUM SUMMARY OF BIT225-012 DESIGN)
Its states primary end point was nasal swabs – not meet
It states secondary objectives are the bloods “Characterisedisease-specific immune and inflammatory markers, including CD8 counts, CD4/CD8ratio, pro-inflammatory cytokines, including IL-1β, IL-6, and markers ofinflammation, such as sCD163”
They have not yet reported on the secondary objectives – so still in play?
$10 Billion Deal, page-13306
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.14M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.9¢ | $1.19K | 62.63K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1774771 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.9¢ | 240722 | 1 |
View Market Depth
| Last trade - 10.18am 27/09/2024 (20 minute delay) ? |
| BIT (ASX) Chart |